Australia Markets open in 5 hrs 26 mins

Trinity Biotech plc (TRIB)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
1.4100+0.0100 (+0.71%)
As of 02:08PM EDT. Market open.
Currency in USD

Valuation measures4

Market cap (intra-day) N/A
Enterprise value N/A
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)N/A
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 1.33
52-week change 3N/A
S&P500 52-week change 3N/A
52-week high 33.0500
52-week low 30.8600
50-day moving average 31.3390
200-day moving average 31.3645

Share statistics

Avg vol (3-month) 356.7k
Avg vol (10-day) 346.64k
Shares outstanding 520.9M
Implied shares outstanding 6N/A
Float 819.16M
% held by insiders 111.63%
% held by institutions 143.15%
Shares short (14 July 2022) 4452.58k
Short ratio (14 July 2022) 48.22
Short % of float (14 July 2022) 4N/A
Short % of shares outstanding (14 July 2022) 41.19%
Shares short (prior month 14 June 2022) 4478.66k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 3N/A
Trailing annual dividend yield 3N/A
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 330 June 2015
Ex-dividend date 404 June 2015
Last split factor 21:4
Last split date 301 June 2005

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2021
Most-recent quarter (mrq)30 Mar 2022


Profit margin -15.10%
Operating margin (ttm)6.96%

Management effectiveness

Return on assets (ttm)3.10%
Return on equity (ttm)N/A

Income statement

Revenue (ttm)86.15M
Revenue per share (ttm)3.95
Quarterly revenue growth (yoy)-26.60%
Gross profit (ttm)38.08M
Net income avi to common (ttm)-12.95M
Diluted EPS (ttm)-0.3770
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)10.01M
Total cash per share (mrq)0.41
Total debt (mrq)89.73M
Total debt/equity (mrq)N/A
Current ratio (mrq)3.66
Book value per share (mrq)0.04

Cash flow statement

Operating cash flow (ttm)6.04M
Levered free cash flow (ttm)-13.52M